Benlysta (Belimumab) Infusions
Benlysta is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines.
Generically known as belimumab, Benlysta is approved for use in children ages 5 years and older who have SLE or other lupus medicines.
Drug manufacturer information for Benlysta is available here.
Indication:
Systemic lupus erythematosus
Benlysta Infusion Duration:
Frequency:
Loading Dose: 3 infusions given over 6 weeks at 2-week intervals
Maintenance Dose: Every 4 weeks